Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab

Most studies of methotrexate (MTX) in combination with tumor necrosis factor (TNF) inhibitors have focused on treatment-naive patients with early disease. The goal of this study was to evaluate whether previous biologic therapy influenced the impact of concomitant MTX in patients initiating treatmen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Schmalzing, Marc, Behrens, Frank, Schwaneck, Eva C., Koehm, Michaela, Greger, Gerd, Gnann, Holger, Burkhardt, Harald, Tony, Hans-Peter
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2020
Assuntos:
6900
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7220320/
https://ncbi.nlm.nih.gov/pubmed/32384515
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000020201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados